Pamisel, Top Search Ranking... Stock Price -1.47%

Pamiscell is trading at 23,500 KRW as of 12:30 PM on the 27th, down 1.47% from the previous day. This represents a 23.68% increase compared to April 24. Pamiscell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Today, foreigners have net sold 23,000 shares of Pamiscell, while institutions have net bought 21,000 shares, according to provisional data. Over the past five days, individual investors have net bought 1,363 shares, while foreigners and institutions have net sold 60,335 shares and net bought 66,046 shares, respectively.

On May 26, Pamiscell was a market topic with the headline "Remdesivir Special Import Possible... Bullish."

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.